Over the last 7 days, the Biotech industry has risen 2.0%, driven by gains from Idorsia of 7.2%. In contrast, the industry has lost 60% in the last 12 months. Earnings are forecast to grow by 9.3% annually.
Has the Swiss Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Wed, 07 Jun 2023 | CHF325.2m | CHF334.1m | -CHF181,188,533.00 | n/a | -1.8x | 1x |
Fri, 05 May 2023 | CHF381.0m | CHF496.3m | -CHF18,252,374.00 | 1.7x | -20.9x | 0.8x |
Sun, 02 Apr 2023 | CHF428.2m | CHF497.3m | CHF12.3m | 1.5x | 34.8x | 0.9x |
Tue, 28 Feb 2023 | CHF490.4m | CHF493.4m | CHF14.5m | 1.6x | 33.8x | 1x |
Thu, 26 Jan 2023 | CHF511.5m | CHF493.4m | CHF14.5m | 1.7x | 35.3x | 1x |
Sat, 24 Dec 2022 | CHF501.6m | CHF493.4m | CHF14.5m | 1.7x | 34.6x | 1x |
Mon, 21 Nov 2022 | CHF515.5m | CHF494.8m | CHF14.5m | 1.8x | 35.6x | 1x |
Wed, 19 Oct 2022 | CHF509.7m | CHF510.1m | CHF15.9m | 1.9x | 32.1x | 1x |
Fri, 16 Sep 2022 | CHF529.0m | CHF495.8m | CHF27.8m | 1.9x | 19x | 1.1x |
Sun, 14 Aug 2022 | CHF527.5m | CHF482.7m | CHF38.7m | 1.9x | 13.6x | 1.1x |
Tue, 12 Jul 2022 | CHF585.5m | CHF460.6m | CHF81.6m | 2.2x | 7.2x | 1.3x |
Thu, 09 Jun 2022 | CHF626.5m | CHF470.6m | CHF25.0m | 2.1x | 25x | 1.3x |
Sat, 07 May 2022 | CHF721.2m | CHF301.5m | -CHF144,267,932.00 | 1.9x | -5x | 2.4x |
Mon, 04 Apr 2022 | CHF1.2b | CHF288.4m | -CHF143,186,966.00 | 2x | -8.2x | 4.1x |
Wed, 02 Mar 2022 | CHF1.3b | CHF281.4m | -CHF139,079,671.00 | 2x | -9.5x | 4.7x |
Fri, 28 Jan 2022 | CHF5.2b | CHF320.6m | -CHF658,577,634.00 | 1.5x | -7.9x | 16.3x |
Sun, 26 Dec 2021 | CHF4.2b | CHF317.4m | -CHF659,020,639.00 | 1.5x | -6.3x | 13.2x |
Tue, 23 Nov 2021 | CHF3.8b | CHF320.3m | -CHF658,611,195.00 | 1.5x | -5.7x | 11.8x |
Thu, 21 Oct 2021 | CHF4.7b | CHF304.9m | -CHF641,744,123.00 | 2.3x | -7.3x | 15.3x |
Sat, 18 Sep 2021 | CHF5.3b | CHF302.6m | -CHF612,743,058.00 | 1.3x | -8.6x | 17.4x |
Mon, 16 Aug 2021 | CHF5.4b | CHF306.0m | -CHF612,309,374.80 | 1.1x | -8.8x | 17.6x |
Mon, 31 May 2021 | CHF5.8b | CHF352.3m | -CHF535,605,963.80 | 1.1x | -10.8x | 16.4x |
Thu, 04 Mar 2021 | CHF6.2b | CHF407.2m | -CHF561,055,198.50 | 6x | -11.1x | 15.3x |
Sun, 06 Dec 2020 | CHF6.5b | CHF399.6m | -CHF565,530,866.50 | 7.1x | -11.5x | 16.3x |
Wed, 09 Sep 2020 | CHF6.0b | CHF393.6m | -CHF565,357,804.50 | 496.9x | -10.6x | 15.2x |
-8.7x
Which industries have driven the changes within the Swiss Healthcare industry?
CH Market | 1.21% | |
Healthcare | 2.60% | |
Biotech | 1.98% | |
Biotech | 1.98% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
IDIA Idorsia | CHF8.24 | 7.2% +CHF97.9m | -45.7% | PS13x | |
MOLN Molecular Partners | CHF6.10 | 6.5% +CHF12.1m | -14.1% | PS10.1x | |
SANN Santhera Pharmaceuticals Holding | CHF0.92 | 12.7% +CHF12.0m | -12.2% | PS14.3x | |
KURN Kuros Biosciences | CHF1.38 | 3.4% +CHF1.6m | -29.1% | PS2.8x | |
SPEX Spexis | CHF0.35 | 0.6% +CHF1.1m | -66.5% | PS12.5x |